Outcomes of Radiosurgery for WHO Grade 2 Meningiomas: The Role of Ki-67 Index in Guiding the Tumor Margin Dose
Ying Meng(Sunnybrook Health Science Centre), Douglas Kondziolka(Neurological Surgery), John G. Golfinos(NYU Langone Health), Donato Pacione(New York University), Elad Mashiach(New York University), Erik P. Sulman(NYU Langone Health), Nivedha Kannapadi(New York University), Matija Snuderl, Joshua S. Silverman(NYU Langone Health), Brandon Santhumayor(North Shore Diabetes and Endocrine Associates), Jason Gurewitz(New York University), Chandranath Sen(NYU Langone Health), Bernadine R. Donahue(Maimonides Medical Center), Kenneth E. Bernstein(Cedars-Sinai Medical Center)
Cited by 7
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k